Drug Shortage Report for VORICONAZOLE FOR INJECTION

Last updated on 2022-12-04 History
Report ID 154479
Drug Identification Number 02493829
Brand name VORICONAZOLE FOR INJECTION
Common or Proper name Voriconazole for Injection, 200mg SD Vial 30mL
Company Name FRESENIUS KABI CANADA LTD
Market Status MARKETED
Active Ingredient(s) VORICONAZOLE
Strength(s) 200MG
Dosage form(s) POWDER FOR SOLUTION
Route of administration INTRAVENOUS
Packaging size 30mL
ATC code J02AC
ATC description ANTIMYCOTICS FOR SYSTEMIC USE
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2022-02-01
Estimated end date 2022-11-30
Actual end date 2022-11-30
Shortage status Resolved
Updated date 2022-12-04
Company comments Effective May 2, 2022 this product will be placed on allocation. Contract customers will be allocated 100% of historical monthly demand.
Health Canada comments
Tier 3 Status No
Contact Address 165 GALAXY BLVD, SUITE 100
TORONTO, ONTARIO
CANADA M9W 0C8
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v18 2022-12-04 French Compare
v17 2022-12-04 English Compare
v16 2022-11-03 French Compare
v15 2022-11-03 English Compare
v14 2022-10-03 French Compare
v13 2022-10-03 English Compare
v12 2022-10-02 French Compare
v11 2022-10-02 English Compare
v10 2022-07-07 French Compare
v9 2022-07-07 English Compare
v8 2022-05-02 French Compare
v7 2022-05-02 English Compare
v6 2022-05-02 French Compare
v5 2022-05-02 English Compare
v4 2022-04-13 French Compare
v3 2022-04-13 English Compare
v2 2022-02-08 French Compare
v1 2022-02-08 English Compare

Showing 1 to 18 of 18